Medline (MDLN) Non-Current Deferred Tax Liability (2025 - 2026)

Name: Medline (MDLN) Non-Current Deferred Tax Liability (2025 - 2026) | Business Quant
Creator: Business Quant

Medline (MDLN) reported Non-Current Deferred Tax Liability of $4.0 billion for Q1 2026, up 13.18% on a QoQ basis from $3.5 billion in Q4 2025.

Medline (MDLN) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $4.0 billion in Q1 2026.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $4.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 billion (changed N/A YoY) and the FY2025 annual result came in at $3.5 billion, changed N/A from the prior year.
Non-Current Deferred Tax Liability grew to $4.0 billion in Q1 2026 per MDLN's latest filing, from $3.5 billion in the prior quarter.
Across five years, Non-Current Deferred Tax Liability topped out at $4.0 billion in Q1 2026 and bottomed at $3.5 billion in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	146.28 Bn	141.88 Bn	1.83 Bn
2	Becton Dickinson	41.14 Bn	40.13 Bn	2.15 Bn
3	Medline	29.16 Bn	35.00 Bn	1.84 Bn
4	Resmed	27.13 Bn	25.47 Bn	890.98 Mn
5	West Pharmaceutical Services	22.71 Bn	22.19 Bn	296.40 Mn
6	Solventum	13.26 Bn	13.26 Bn	1.10 Bn
7	Align Technology	12.22 Bn	11.16 Bn	736.59 Mn
8	Cooper Companies	11.79 Bn	11.66 Bn	695.20 Mn
9	Baxter International	9.47 Bn	7.42 Bn	891.00 Mn
10	Aptargroup	7.19 Bn	6.99 Bn	351.91 Mn

Download Data 🔒